CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 541 enrolled
Drug / intervention
Naproxen sodium and caffeine (BAY2880376) +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05485805
NCT05485805Phase 3Completed

A Randomized, Double-Blind, Single-Dose, Parallel, Placebo-Controlled Pivotal Trial to Confirm the Efficacy of a Fixed Dose Combination Tablet of Naproxen Sodium and Caffeine to Effectively Alleviate Postsurgical Dental Pain

Bayer·interventional·Posted Aug 3, 2022·Updated Mar 25, 2025

In Brief

A Phase 3 clinical trial evaluating Naproxen sodium and caffeine (BAY2880376), Naproxen sodium (Aleve), and 2 other interventions for Postoperative Dental Pain. Completed, enrolled 541 participants across 1 site.

Detailed Summary

Researchers are looking for a better way to relieve pain in people, such as after dental surgery. Participants in this study, have had 3 or 4 third molars (cheek teeth) removed and subsequently have moderate to severe tooth pain. The study treatment naproxen sodium suppresses inflammatory pain by reducing inflammation. In the US, naproxen has been marketed since 1976, and naproxen sodium has been approved for over-the-counter (OTC) use since 1994 for the temporary relief of minor aches and pains. Caffeine, which is generally consumed as coffee, tea, or cocoa, has been shown to enhance the effect of various painkillers, and therefore is accepted as an additive. The main purpose of this study is to learn how well a fixed-dose combination of naproxen sodium and caffeine relieves pain compared to each single ingredient as well as to placebo in participants after molar removal. A placebo is a treatment that looks like a medicine but does not have any medicine in it. To answer this, the researchers will compare the amount of pain decrease over 8 hours in participants who received a single dose of either: * 1 fixed-dose tablet of naproxen sodium/caffeine * 2 fixed-dose tablets of naproxen sodium/caffeine * naproxen sodium only * caffeine only * or placebo The study participants will be randomly (by chance) assigned to one of the five treatment groups. They will take a single dose of two tablets by mouth within 4.5 hours after the surgery. If there is no pain relief within 2 hours after intake, other painkillers may be given.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2023202420252026
First PostedAug 3, 2022
Enrollment StartSep 21, 2022
Primary CompletionJan 25, 2024
Study CompletionJan 29, 2024
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 3.9 years ago

Interventions

Naproxen sodium and caffeine (BAY2880376)drug

Tablet, oral use, single dose

Naproxen sodium (Aleve)drug

Tablet, oral use, single dose

Caffeinedrug

Tablet, oral use, single dose

Placebodrug

Tablet, oral use, single dose